Kalmon D Post Selected Research

Acromegaly

4/2021	Prognostic value of nadir GH levels for long-term biochemical remission or recurrence in surgically treated acromegaly.
12/2015	IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition.
8/2015	Adipose Tissue Redistribution and Ectopic Lipid Deposition in Active Acromegaly and Effects of Surgical Treatment.
11/2014	Prospective study of surgical treatment of acromegaly: effects on ghrelin, weight, adiposity, and markers of CV risk.
2/2010	Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed.
4/2005	Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly.
2/2004	Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels.
1/2004	Cabergoline therapy of growth hormone & growth hormone/prolactin secreting pituitary tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kalmon D Post Research Topics

Disease

8	Acromegaly 04/2021 - 01/2004
8	Pituitary ACTH Hypersecretion 01/2021 - 06/2005
7	Neoplasms (Cancer) 02/2021 - 08/2002
6	Insulin Resistance 01/2017 - 04/2005
5	Pituitary Neoplasms (Pituitary Adenoma) 12/2015 - 08/2002
3	Adenoma (Adenomas) 12/2012 - 12/2002
2	ACTH-Secreting Pituitary Adenoma 01/2021 - 01/2017
2	Stroke (Strokes) 09/2020 - 12/2012
2	Hypopituitarism (Sheehan's Syndrome) 04/2020 - 04/2011
2	Meningioma (Meningiomas) 09/2016 - 10/2003
2	Obesity 04/2016 - 10/2010
2	Cushing Syndrome 12/2012 - 12/2008
2	Hyperprolactinemia 01/2004 - 08/2002
1	Carcinoma (Carcinomatosis) 01/2021
1	Necrosis 09/2020
1	Hemorrhage 09/2020
1	Abdominal Obesity 01/2017
1	Inflammation (Inflammations) 01/2017
1	Lipodystrophy 08/2015
1	Body Weight (Weight, Body) 11/2014
1	Infarction (Infarctions) 12/2012
1	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2006
1	Empty Sella Syndrome 09/2005
1	Astrocytoma (Pilocytic Astrocytoma) 03/2005
1	Diabetes Insipidus 10/2004
1	Cysts 10/2004
1	Oligomenorrhea 12/2002
1	Ovarian Cysts (Ovarian Cyst) 12/2002
1	Amenorrhea 12/2002
1	Infertility (Sterility) 12/2002
1	Cerebrospinal Fluid Leak 08/2002
1	Prolactinoma (Prolactinomas) 08/2002
1	Hematoma 08/2002

Drug/Important Bio-Agent (IBA)

9	Insulin-Like Growth Factor I (IGF-1)IBA 04/2021 - 01/2004
5	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021 - 12/2008
4	Glucose (Dextrose)FDA LinkGeneric 04/2021 - 02/2004
4	Hormones (Hormone)IBA 04/2011 - 01/2004
3	Insulin (Novolin)FDA Link 08/2015 - 04/2005
3	Growth Hormone (Somatotropin)IBA 01/2007 - 01/2004
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2007
2	GlucocorticoidsIBA 01/2017 - 10/2010
2	LipidsIBA 08/2015 - 05/2012
2	C-Reactive ProteinIBA 11/2014 - 05/2012
2	LeptinIBA 11/2014 - 05/2012
2	Bromocriptine (Parlodel)FDA LinkGeneric 01/2004 - 08/2002
2	ProlactinIBA 01/2004 - 08/2002
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2004 - 08/2002
1	Fluorescent Dyes (Fluorescent Probes)IBA 02/2021
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2021
1	Follicle Stimulating Hormone (Follitropin)FDA Link 09/2020
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 09/2020
1	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 01/2017
1	CytokinesIBA 01/2017
1	HomocysteineIBA 11/2014
1	GhrelinIBA 11/2014
1	HDL LipoproteinsIBA 11/2014
1	Triglycerides (Triacylglycerol)IBA 11/2014
1	Lipoprotein(a)IBA 11/2014
1	AdiponectinIBA 05/2012
1	CholesterolIBA 05/2012
1	AdipokinesIBA 05/2012
1	Codon (Codons)IBA 01/2007
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 03/2006
1	SiliconesIBA 09/2005
1	Biomarkers (Surrogate Marker)IBA 04/2005
1	antineoplaston A10 (A 10)IBA 10/2004
1	Cabergoline FDA LinkGeneric 01/2004
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 12/2002
1	Estradiol (Delestrogen)FDA LinkGeneric 12/2002
1	Leuprolide (Lupron)FDA LinkGeneric 12/2002

Therapy/Procedure

5	Therapeutics 04/2020 - 08/2002
1	Length of Stay 09/2016
1	Aftercare (After-Treatment) 04/2016
1	Hypophysectomy 06/2005
1	Radiotherapy 03/2005
1	Decompression 10/2004